Genome Biology 'Under Review': What Each Status Means and When to Expect a Decision

Before the paper reaches external reviewers, a BMC handling editor at Genome Biology evaluates whether the genomics-methodology or biological-discovery significance warrants Genome Biology's selective editorial slots. Roughly 70 percent of submissions are rejected at this stage within the 14-day median first-decision window. A desk rejection most often means the handling editor concluded that the work would fit better at a sister BMC title (BMC Genomics for broader genomics, BMC Bioinformatics for methods-only) or that the broad-genomics audience appeal is uncertain.

The BMC editorial office confirms files are complete: manuscript with figures embedded, supplementary information separate, reporting checklists where applicable (ARRIVE for animal work, MIQE for quantitative PCR, STROBE for observational genomics studies including GWAS), cover letter directed to the editor, conflict-of-interest declarations, ethics-statement documentation, IRB approvals for human-subjects research, and data-availability statements (BMC requires raw sequencing data deposition).

The handling editor reads the paper and evaluates scientific robustness, originality, and clarity per BMC's three explicit criteria. The 14-day median first-decision target reflects fast editorial response.

In parallel with the handling editor's primary read, ambiguous-fit papers are discussed at the BMC editor meeting where peer handling editors at sister BMC titles weigh in on whether the paper would fit better at Genome Biology, BMC Genomics, or BMC Bioinformatics. This editorial-team discussion runs alongside the desk-screen and adds 3 to 5 days to the timeline that is invisible to the author in the portal.

BMC handling editors at Genome Biology typically invite 2 to 3 expert reviewers. The recruitment window can take 7 to 14 days because genomics-methodology reviewers with topic-matched expertise (e.g., single-cell genomics, structural genomics, machine-learning genomics) are scarce. When BMC journals cannot find sufficient reviewers, American Journal Experts (AJE) may identify suitable reviewers and pay them a small honorarium for completing the review within a specified timeframe.

Once reviewers agree to review, the typical Genome Biology peer-review cycle lasts 4 to 8 weeks. Reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. Reviewers are asked to evaluate scientific robustness, originality, and clarity per BMC's three explicit criteria. Reviewer reports for Genome Biology tend to be thorough; 2000 to 4000 word reports are typical for genomics methodology papers.

After reports return, the handling editor synthesizes them. The 270-day median submission-to-acceptance timeline reflects multiple revision rounds typical for genomics methodology papers; first decisions arrive in 14 days median but accepted papers commonly take 6 to 9 months total.

• Rejection within 1 to 5 days: Administrative issue or immediate scope mismatch.
• Rejection within 1 to 2 weeks: Handling editor desk rejection per the 14-day median.
• Still Under Review after 3 weeks: Strong signal. Paper passed the steepest BMC filter.
• Still Under Review after 8 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry via the submission portal is appropriate.
• Status changes to "Reports Received": Reports are in; expect a decision within 1 to 2 weeks.

This is the most common anxiety we hear from Genome Biology authors during the active editorial window. The honest answer: no, 4 weeks at Under Review puts you past the 14-day median first editorial decision and in active external peer review. Reports may be arriving with reviewers in the synthesis phase. Most reviewer-driven delays come from reviewer-recruitment timing for genomics-methodology specialists rather than slow reviews. If the portal still says Under Review at the 6-week mark, the most likely explanation is that one of the assigned reviewers asked for an extension and the handling editor granted it, or that the handling editor invoked the AJE backup reviewer service to find a third reviewer. This is normal practice at BMC.

What you should NOT do during the 4-to-6-week window is email the editorial office. BMC handling editors at Genome Biology are managing 30+ active papers; an inquiry at 4 weeks adds friction without accelerating the timeline.

If your Genome Biology paper is rejected after review, the natural cascade depends on what the reviewers and handling editor cited:

BMC Genomics is the most natural BMC cascade for broader-genomics papers where the Genome Biology selectivity is the concern. BMC supports manuscript-transfer within the BMC family with reviewer reports preserved. BMC Genomics operates a transparent peer review system distinct from Genome Biology's single-anonymous model.

BMC Bioinformatics is the BMC cascade for methods-only genomics papers where the biological-application framing is weaker than the methodology contribution.

Nucleic Acids Research (NAR) is the OUP cascade option for nucleic-acid-focused genomics papers. OUP operates independently from BMC; reports do not transfer.

Cell Genomics is a Cell Press cascade option for top-tier genomics papers where the Cell Press transparent peer-review model fits.

BMC asks reviewers at Genome Biology to evaluate three things specifically. The table below maps each to actionable preparation.

Three patterns generate the most consistent reviewer concerns we see at Genome Biology.

Methods documentation gaps surface as reviewer requests for clarification. When computational methods documentation is thin (especially for custom pipelines, parameter choices, or benchmark comparisons), BMC reviewers consistently request expanded methods sections before issuing a final decision. The strongest revisions add detailed code documentation with version control, parameter justifications, and benchmark comparisons.

Originality framing under-stated. When the introduction does not explicitly compare to prior published work, BMC reviewers consistently flag originality concerns per the three explicit criteria. The strongest manuscripts frame the introduction with explicit prior-work comparison tables.

BMC venue mismatch flagged by handling editor. When the handling editor concludes the work is sound but the broad-genomics audience appeal is uncertain, transfer offers to BMC Genomics or BMC Bioinformatics are common. BMC editors take these transfers seriously and may suggest them during desk screen.

This page was created from BMC's public author guidance at genomebiology.biomedcentral.com/submission-guidelines/peer-review-policy, BMC editorial documentation including the 14-day median first decision and 270-day median submission-to-acceptance, BMC three-criteria evaluation framework (scientific robustness, originality, clarity), American Journal Experts backup-reviewer service documentation, and Manusights pre-submission review experience with Genome Biology-targeted manuscripts.

For the BMC genomics landscape beyond Genome Biology, see BMC Genomics (broader genomics, transparent peer review), BMC Bioinformatics (methods-only), BMC Biology (broader biology), and sister genomics titles (Nucleic Acids Research, Cell Genomics, Nature Genetics). The choice across these titles depends on whether the central contribution is broad-genomics-with-biology (Genome Biology), broader-genomics (BMC Genomics), methods-only (BMC Bioinformatics), nucleic-acid-focused (NAR), Cell-Press-tier (Cell Genomics), or Nature-Portfolio-tier (Nature Genetics).

Reviewers at Genome Biology typically draw from one genomics-methodology specialist and one biological-application reviewer. Preparing a response template that addresses both perspectives accelerates revision rounds substantially given the 270-day median acceptance timeline.

For a pre-upload check of your manuscript against the Genome Biology scientific-robustness-plus-originality bar before submission, our Genome Biology pre-submission diagnostic flags the methods-documentation gaps and originality-framing weaknesses most likely to surface in reviewer reports.